vimarsana.com

Page 54 - ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rise in Advanced Cancers; End-of-Life Care for Kids; No Timeline for Grief

email article As some experts predicted, the sharp decline in cancer screening during the height of the COVID-19 pandemic in 2020 has fueled an increase in the number of diagnoses of advanced-stage cancers. ( ProPublica) The American Cancer Society addresses patients and families questions about COVID-19. A California appeals court affirmed a $500,000 award to the children of a woman who sued her employer for firing her after a breast cancer diagnosis and who died during the initial trial. ( Society for Human Resource Management) Pfizer paused enrollment in a trial of the B-cell maturation antigen-CD3 bispecific antibody elranatamab for multiple myeloma, after several patients developed peripheral neuropathy. (

Scientific Publishing Is a Joke

Scientific Publishing Is a Joke Benjamin Mazer © Adam Maida / The Atlantic / Getty A real scientific advance, like a successful date, needs both preparation and serendipity. As a tired, single medical student, I used to feel lucky when I managed two good dates in a row. But career scientists must continually create this kind of magic. Universities judge their research faculty not so much by the quality of their discoveries as by the number of papers they’ve placed in scholarly journals, and how prestigious those journals happen to be. Scientists joke (and complain) that this relentless pressure to pad their résumés often leads to flawed or unoriginal publications. So when Randall Munroe, the creator of the long-running webcomic

Linnea Sue (Duff) Strottmann

The virus that causes COVID-19 evolved to do one thing: replicate. That means the virus establishes an infection in a host where the virus instructs host cells to make many copies of the virus for the sole purpose of having a chance to reach a new host. This is a relentless process of replic… More Headlines

Introducing RESONIC™ - GuruFocus com

Introducing RESONIC™ Confirm Soliton, Inc. Rolls Out Its Rapid Acoustic Pulse Technology with a Multi-Platform Device Indicated for Tattoo Removal and Cellulite Treatment with First Shipments in June PR Newswire HOUSTON, May 5, 2021 HOUSTON, May 5, 2021 /PRNewswire/ Soliton, Inc., (Nasdaq: SOLY) ( Soliton or the Company ), a medical device company with a novel and proprietary aesthetic platform technology, today announced the launch of its highly anticipated Rapid Acoustic Pulse (RAP) device RESONIC. The dual-platform RESONIC device utilizes a first-of-its-kind technology and offers a paradigm-shifting approach to two in-demand procedures: tattoo removal and cellulite treatment. Harnessing the power of sound, RESONIC helps achieve 75% greater fading of tattoos in as few as 3 sessions and improves the appearance of cellulite non-invasively with high patient satisfaction after just 1 treatment session.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.